Table 1. Hemodynamics.

		AS: Phenylephrine			AS: Dobutamine		2-way ANOVA
		FAST (n=6)	IL (n=6)	HIEG+IL (n=6)	FAST (n=4)	HIEG (n=4)
							BL vs. AS	Intervention	Interaction
HR bpm	BL	96 ± 28	103 ± 17	125 ± 20*	77 ± 15	92 ± 13	P < 0.0001	P = 0.06	P < 0.001
	AS	92 ± 18*	112 ± 18	134 ± 19	149 ± 29	134 ± 55
SBP mm Hg	BL	90 ± 13	79 ± 12	83 ± 11	101 ± 14	103 ± 21**	P < 0.0001	P < 0.05	NS
	AS	136 ± 31	102 ± 24	112 ± 24	117 ± 6	142 ± 11**
DBP mm Hg	BL	55 ± 8	49 ± 10	44 ± 10*	62 ± 9	60 ± 15	P < 0.0001	NS	P < 0.05
	AS	85 ± 24	61 ± 17	63 ± 22	58 ± 9	77 ± 11
RPP SBP*HR	BL	8,601 ± 2,759	7,593 ± 1,744	10,461 ± 2,764	7,837 ± 2,669	9,201 ± 498	P < 0.0001	NS	NS
	AS	11,798 ± 5,101	11,128 ± 2,052	14,590 ± 4,081	17,462 ± 4,299	18,685 ± 7,382

AS – adrenergic stimulation; BL – baseline; FAST – fasted; IL – Intralipid; HIEG – hyperinsulinemic-euglycemic clamp; HR - heart rate; SBP – systolic blood pressure; DBP – diastolic blood pressure; RPP - rate pressure product.

^*P < 0.05 vs. FAST in dobutamine study;

^**P < 0.05 vs. IL;

NS – not significant.